Invitae Reports $460.4 Million in Annual Revenue Driven by 1.17 Million in Billable Volume in 2021
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the fourth quarter and year ended...
United States Sean George Development Expense Stratify Genomics Inc Invitae Corporation Fourth Quarter
Source: prnewswire.com